红花(Carthamus tinctorius L.)中的红花黄色素通过 Nrf2 通路发挥抗氧化和肝保护作用,对抗 CCl(4)-诱导的大鼠肝损伤。
Carthamus red from Carthamus tinctorius L. exerts antioxidant and hepatoprotective effect against CCl(4)-induced liver damage in rats via the Nrf2 pathway.
机构信息
Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, Wuhan University School of Pharmaceutical Sciences, PR China.
出版信息
J Ethnopharmacol. 2013 Jul 9;148(2):570-8. doi: 10.1016/j.jep.2013.04.054. Epub 2013 May 14.
ETHNOPHARMACOLOGICAL RELEVANCE
Carthamus red isolated from safflower (Carthamus tinctorius L., a Chinese traditional medicine) is evaluated for antioxidant and hepatoprotective activity.
MATERIALS AND METHODS
Carthamus red was isolated from a Na2CO3 extract of safflower and its analysis was carried out by HPLC/MS. Acute toxicity study was determined and the antioxidant activity was investigated using various established in vitro systems. An in vivo study against CCl4-induced liver injury was also conducted and compared with that of silymarin, a known hepatoprotective drug.
RESULTS
Carthamus red did not show any toxicity and mortality up to 2000mg/kg dose, and it showed strong antioxidant ability in vitro. In the in vivo study, carthamus red treatment lowered the serum levels of ALT, AST, ALP and total protein in liver damage rat models. Meanwhile, Nrf2, GSTα and NQO1 expressions were up-regulated at the protein level by carthamus red intervention. Additionally, the activities of antioxidant enzymes and level of GSH were elevated by carthamus red intervention, while the content of TBARS, which is an oxidative stress marker, was lessened. HE stain analysis showed that the condition of liver damage was mitigated.
CONCLUSION
This study demonstrates that carthamus red may serve as a candidate with strong a hepatoprotective effect and antioxidant activity in liver damage.
民族药理学相关性
红花中的红花红色素(红花,一种中国传统药物)被评估具有抗氧化和保肝活性。
材料与方法
红花红色素从红花的 Na2CO3 提取物中分离出来,并通过 HPLC/MS 进行分析。进行了急性毒性研究,并使用各种已建立的体外系统研究了抗氧化活性。还进行了红花红色素对 CCl4 诱导的肝损伤的体内研究,并与已知的保肝药物水飞蓟素进行了比较。
结果
红花红色素在高达 2000mg/kg 剂量时没有显示出任何毒性和死亡率,并且在体外具有很强的抗氧化能力。在体内研究中,红花红色素治疗降低了肝损伤大鼠模型中血清 ALT、AST、ALP 和总蛋白的水平。同时,红花红色素干预上调了 Nrf2、GSTα 和 NQO1 的蛋白表达水平。此外,红花红色素干预提高了抗氧化酶的活性和 GSH 的水平,同时减少了氧化应激标志物 TBARS 的含量。HE 染色分析表明,肝损伤的情况得到了缓解。
结论
本研究表明,红花红色素可能是一种具有强大保肝作用和抗氧化活性的候选药物,可用于肝损伤。